SCHEMBL31628017

SCHEMBL31628017

N#CC1(c2nnc(-c3ccc4c(c3)NC(=O)[C@@H](OC(N)=O)CS4)o2)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31628288 0.84 KDM4E (0.33) —
SCHEMBL31628007 0.83 — —
SCHEMBL31628259 0.79 GAA (0.33) —
SCHEMBL31375516 0.79 GAA (0.33) —
SCHEMBL30830334 0.79 BACE1 (0.32) —
SCHEMBL31628145 0.76 HDAC6 (0.31) —
SCHEMBL30830349 0.76 HDAC1 (0.30) —
SCHEMBL31628226 0.71 — —
SCHEMBL30830296 0.68 HSD17B10 (0.42) —
SCHEMBL31628162 0.67 HTT (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568959-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-06-18 — — EP disclosed
Send feedback